Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $17.4 million.

  • Lemaitre Vascular's Income towards Parent Company rose 5583.88% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 2799.2%. This contributed to the annual value of $43.6 million for FY2024, which is 4478.33% up from last year.
  • Lemaitre Vascular's Income towards Parent Company amounted to $17.4 million in Q3 2025, which was up 5583.88% from $13.8 million recorded in Q2 2025.
  • Lemaitre Vascular's Income towards Parent Company's 5-year high stood at $17.4 million during Q3 2025, with a 5-year trough of $3.5 million in Q2 2022.
  • In the last 5 years, Lemaitre Vascular's Income towards Parent Company had a median value of $8.1 million in 2023 and averaged $8.6 million.
  • In the last 5 years, Lemaitre Vascular's Income towards Parent Company surged by 13711.43% in 2021 and then plummeted by 5764.55% in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Income towards Parent Company stood at $6.2 million in 2021, then fell by 11.82% to $5.4 million in 2022, then surged by 55.46% to $8.5 million in 2023, then rose by 26.79% to $10.7 million in 2024, then soared by 61.76% to $17.4 million in 2025.
  • Its Income towards Parent Company stands at $17.4 million for Q3 2025, versus $13.8 million for Q2 2025 and $11.0 million for Q1 2025.